ArticleSAGE open nursing
Fatal and Non-fatal Health Outcomes of Congenital Musculoskeletal and Limb Anomalies Among Infants in Eastern Sub-Saharan Africa, From 1990 to 2023.
Article in SAGE open nursing. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite strategies and policies, congenital musculoskeletal and limb anomalies (CMLAs) remain a public health issue for infants in low-income countries. However, the true burden of these anomalies is not well documented in resource-limited settings. Objective: This study aimed to quantify the non-fatal and fatal health impacts of CMLAs in the Eastern Sub-Saharan African (ESSA) region from 1990 to 2023. Methods: The Global Burden of Diseases (GBD) 2023 methods and tools were used. Prevalence, incidence, and years lived with disability (YLDs) were estimated by using the Bayesian meta-regression tool for disease modeling (DisMod-MR 2.1), whereas mortality and years of life lost (YLLs) rates were quantified in the cause of death ensemble model (CODEm). Results: In the ESSA region, there were an estimated 1606 prevalent cases of CMLAs (95% UI: 1112, 2299), 2120 new cases (95% UI: 1472, 3016), 4 deaths (95% UI: 2, 10), 389 YLLs (95% UI: 186, 858), 241 YLDs (95% UI: 140, 400), and 630 DALYs (95% UI: 383, 1069) per 100,000 infants in 2023. Somalia had the highest non-fatal rates, while Mozambique had the highest fatal rates. The lowest YLLs rate was among males in Ethiopia. Between 1990 and 2023, the rates remained similar across the region. However, there was a 6% decline in the incidence rate (95% UI: -10, -1). The non-fatal health outcomes increased in Kenya. Conclusion: This study revealed that the fatal and non-fatal outcomes of CMLAs were high and remained similar across most countries in the ESSA region over the past 34 years, indicating the need for targeted interventions to mitigate the burden. Implementing community-based screening, treatment, and counseling programs; establishing dedicated pediatric surgical care and rehabilitation centers; and strengthening comprehensive surveillance systems may be recommended to reduce the premature mortalities and disabilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.